Status:
RECRUITING
ISB With SSNB & ANB
Lead Sponsor:
Chuncheon Sacred Heart Hospital
Conditions:
Rotator Cuff Tear
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This study is a prospective, randomized, double-blind trial comparing patients who underwent arthroscopic rotator cuff repair and received an interscalene brachial plexus block (9 ml of 0.75% ropivaca...
Eligibility Criteria
Inclusion
- a definite rotator cuff tear that needed repair seen on preoperative magnetic resonancce imaging (MRI)
- acceptance of arthroscopic surgery including rotator cuff repair
- age same as or more than 20 years
- acceptance of preemptive regional block and PCA, and blood testing
Exclusion
- did not undergo arthroscopic rotator cuff repair
- stopped PCA before 48 hours postoperatively because of associated side effects
- a history of previous ipsilateral shoulder operation or fracture
- a concomitant neurologic disorder around the shoulder
- a failure of blood sampling including hemolysis, etc.
Key Trial Info
Start Date :
March 24 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06878391
Start Date
March 24 2025
End Date
January 31 2027
Last Update
May 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, Gangwon-do, South Korea, 24253
2
Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, Gangwon-do, South Korea, 24253